Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Colorectal Neoplasms × larotrectinib × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasm Metastasis 1 Lung Neoplasms 1 Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion 1 Locally Advanced Thyroid Gland Carcinoma 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Thyroid Cancer Patients Who Received Target Therapy 1

Interventions

Bevacizumab 59 Cetuximab 41 Fluorouracil 39 pembrolizumab 30 Oxaliplatin 30 Leucovorin 27 Irinotecan 24 Folfox protocol 20 Specimen Handling 18 HMPL-013 17 Capecitabine 17 Blood Specimen Collection 16 trifluridine tipiracil drug combination 13 Magnetic Resonance Spectroscopy 13 Biopsy 11 regorafenib 10 Trifluridine 10 Panitumumab 10 Gemcitabine 10 Carboplatin 10 Nivolumab 9 IFL protocol 9 Drug Therapy 9 Cisplatin 9 encorafenib 8 Standard of Care 8 Interviews as Topic 8 sintilimab 7 Radiosurgery 7 Cyclophosphamide 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05725200 2023-02-21

EVIDENT

Oslo University Hospital

Phase 2 Recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡